Minireviews
Copyright ©The Author(s) 2025.
World J Stem Cells. Feb 26, 2025; 17(2): 103599
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.103599
Table 2 Brief description of four clinical asthma trials related to stem cells in the clinical trials database
NCT No
Title
Disease
Source MSCs
Auto/Allo?
Delivery
Phases
Enrollment
Ages eligible for study
Locations
02192736Safety and feasibility study of intranasal MTF for treatment of asthmaAsthmaUCMSC-CMAllogeneicIntra-nasal1/22018-65 years oldPanama
03137199Allogeneic human MSCs via intravenous delivery in patients with mild asthmaAsthmaBMSCsAllogeneicIV1618-65 years oldUnited States
04883320Stem cell strategies for the treatment of chronic asthmaAsthmaMSCUnspecifiedNot providedNot applicable1518-70 years oldUnited Kingdom
05147688Safety of cultured allogeneic adult umbilical cord-derived mesenchymal stem cells for pulmonary diseasesPulmonary diseases, asthmaUCMSCAllogeneicIV120Child, adult, older adultAntigua and Barbuda